Posted on Leave a comment

Idiopathic Pulmonary Fibrosis Treatment Market Size (7MM) was ~USD 3,300 million in 2023 and is projected to increase by 2034, estimates DelveInsight

DelveInsight’s report titled “Idiopathic Pulmonary Fibrosis Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of burns, historical and forecasted epidemiology, as well as the Idiopathic Pulmonary Fibrosis therapeutics market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. Unlock key insights into […]

Posted on Leave a comment

Creator Priority AI Agent for Creators Now Available on GPT, ChatGPT, and Shopify – Exclusive Founder Deal Inside

Atlanta, GA – Apr 30, 2025 – CREATEIT, a leading platform for creators, is thrilled to announce the official release of the Creator Priority AI Agent. The LITE Version is available to preview for free (valued at $3,333) and is officially listed on GPT, ChatGPT, and the Miss Creator Store on Shopify for creators who […]

Posted on Leave a comment

NexGen Landscaping: Redefining Commercial Landscaping Across Arizona

Tempe, AZ – Apr 30, 2025 – NexGen Landscaping, Arizona’s leading commercial landscaping company, is setting a new benchmark for excellence in the industry. Headquartered in Tempe, AZ, NexGen Landscaping delivers high-quality landscape installation and maintenance services that enhance commercial properties and HOA communities throughout the Phoenix-Metro area. With a steadfast commitment to quality, innovation, […]

Posted on Leave a comment

Closana Launches a New Era of Capital Advisory: Raising Smarter, Faster, and Without the Guesswork

“Blitz Model” by Closana reshapes startup fundraising with execution-first strategies and real investor connections. Closana, a modern capital advisory platform, is setting a new standard for startup fundraising by offering execution-first support that delivers signed term sheets — not just advice. Designed for founders who prioritize results over rhetoric, Closana enables early-stage startups to raise […]

Posted on Leave a comment

Dry Eye Disease Treatment Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials, Medication, Therapies, NICE Approvals, Prevalence, and Companies by DelveInsight

Dry Eye Disease Treatment Market Dry Eye Disease Companies are Palatin Technologies, Inc., Aldeyra Therapeutics, Inc., ReGenTree/RegeneRx Biopharmaceuticals, Inc., Mimetogen, Alcon/Aerie Pharmaceuticals, BRIM Biotechnology, Inc., Seikagaku Corporation, Mitotech, Senju Pharmaceutical, Sylentis, S.A./PharmaMar, Stuart Therapeutics, VivaVision Biotech, HanAll BioPharma Co., Ltd./Daewoong Pharmaceutical Co. Ltd., Redwood Pharma AB, AxeroVision, OKYO Pharma, AxeroVision, AxeroVision., Glaukos Corporation, Oculis, and […]

Posted on Leave a comment

Idiopathic Inflammatory Myositis Market is Projected to Grow at a CAGR of 21.1% by 2034 | DelveInsight

Idiopathic Inflammatory Myositis Market The idiopathic inflammatory myositis treatment market is poised for significant expansion, driven by the introduction of innovative targeted therapies and increasing disease awareness. Key idiopathic inflammatory myositis companies, including Octapharma, Pfizer, Mitsubishi Tanabe Pharma, AstraZeneca, Priovant Therapeutics, and CSL, among others, are advancing the treatment landscape with promising therapies, addressing the […]

Posted on Leave a comment

Philanthropy in Action: Yerkin Tatishev Drives Cultural Legacy at Tsinandali 2025

Yerkin Tatishev, the founder of Kusto Group, is currently busy planning the upcoming Tsinandali Festival 2025 with the co-founders of the festival. The Tsinandali Festival is returning for its seventh edition from September 4 to 14, 2025. Held at the breathtaking Tsinandali Estate in Georgia’s Kakheti wine region, the festival has become a global symbol […]

Posted on Leave a comment

SRJCPA Unveils Wealth Strategy Transforming Credit into Capital for Canada’s Elite

Canadian high-net-worth individuals allocate equal time to liabilities analysis as they do to investment planning during financial meetings today. The most advanced family portfolios borrow against existing securities to increase wealth compounding at tax-efficient rates exceeding their borrowing costs. At first blush, this may sound like a banker’s game, but in practice, every one of […]

Posted on Leave a comment

Allergic Conjunctivitis Clinical Trials Analysis 2025: EMA, PDMA, FDA Approvals, Medication, Therapies, NICE Approvals, Mechanism of Action, ROA, IND, NDA Approval and Companies by DelveInsight

Allergic Conjunctivitis Clinical Trials Allergic Conjunctivitis companies are OKYO Pharma, RAPT Therapeutics, Allakos, Sylentis, Postbiotica, Stuart Therapeutics, Oyster Point Pharma, Bausch Health Companies Inc., Bausch & Lomb Incorporated, Aldeyra Therapeutics, Vanda Pharmaceuticals, Noveome Biotherapeutics, Allakos, Inc., Regeneron Pharmaceuticals, Marinomed Biotech AG, Eleusis Holdings Ltd, IACTA Pharmaceuticals, JW Pharmaceutical, Nanomerics, Marinomed Biotech AG, ILTOO Pharma, Emergo […]